181 related articles for article (PubMed ID: 18303031)
1. Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials.
Collette S; Bonnetain F; Paoletti X; Doffoel M; Bouché O; Raoul JL; Rougier P; Masskouri F; Bedenne L; Barbare JC
Ann Oncol; 2008 Jun; 19(6):1117-26. PubMed ID: 18303031
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of hepatocellular carcinoma in anti-HCV positive cirrhotic patients: a single-centre comparison amongst four different staging systems.
Giannini E; Risso D; Botta F; Romagnoli P; Malfatti F; Fumagalli A; Testa E; Podestà E; Chiarbonello B; Polegato S; Testa R
J Intern Med; 2004 Mar; 255(3):399-408. PubMed ID: 14871465
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of unresectable hepatocellular carcinoma: comparison of seven staging systems (TNM, Okuda, BCLC, CLIP, CUPI, JIS, CIS) in a Chinese cohort.
Zhang JF; Shu ZJ; Xie CY; Li Q; Jin XH; Gu W; Jiang FJ; Ling CQ
PLoS One; 2014; 9(3):e88182. PubMed ID: 24609114
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.
Grieco A; Pompili M; Caminiti G; Miele L; Covino M; Alfei B; Rapaccini GL; Gasbarrini G
Gut; 2005 Mar; 54(3):411-8. PubMed ID: 15710992
[TBL] [Abstract][Full Text] [Related]
5. Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials.
Bonnetain F; Paoletti X; Collette S; Doffoel M; Bouché O; Raoul JL; Rougier P; Masskouri F; Barbare JC; Bedenne L
Qual Life Res; 2008 Aug; 17(6):831-43. PubMed ID: 18618292
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort.
op den Winkel M; Nagel D; Sappl J; op den Winkel P; Lamerz R; Zech CJ; Straub G; Nickel T; Rentsch M; Stieber P; Göke B; Kolligs FT
PLoS One; 2012; 7(10):e45066. PubMed ID: 23071507
[TBL] [Abstract][Full Text] [Related]
7. Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort.
Adhoute X; Pénaranda G; Raoul JL; Edeline J; Blanc JF; Pol B; Campanile M; Perrier H; Bayle O; Monnet O; Beaurain P; Muller C; Castellani P; Le Treut YP; Bronowicki JP; Bourlière M
World J Gastroenterol; 2017 Apr; 23(14):2545-2555. PubMed ID: 28465639
[TBL] [Abstract][Full Text] [Related]
8. External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort study.
Borzio M; Dionigi E; Rossini A; Marignani M; Sacco R; De Sio I; Bertolini E; Francica G; Giacomin A; Parisi G; Vicari S; Toldi A; Salmi A; Boccia S; Mitra M; Fornari F
Hepatology; 2018 Jun; 67(6):2215-2225. PubMed ID: 29165831
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of staging systems for hepatocellular carcinoma in 428 patients treated with radioembolization.
Memon K; Kulik LM; Lewandowski RJ; Wang E; Wang J; Ryu RK; Hickey R; Vouche M; Baker T; Ganger D; Gates VL; Habib A; Mulcahy MF; Salem R
J Vasc Interv Radiol; 2014 Jul; 25(7):1056-66. PubMed ID: 24613269
[TBL] [Abstract][Full Text] [Related]
10. Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt.
Gomaa AI; Hashim MS; Waked I
PLoS One; 2014; 9(3):e90929. PubMed ID: 24603710
[TBL] [Abstract][Full Text] [Related]
11. Selecting an optimal staging system for hepatocellular carcinoma: comparison of 5 currently used prognostic models.
Hsu CY; Hsia CY; Huang YH; Su CW; Lin HC; Lee PC; Loong CC; Chiang JH; Huo TI; Lee SD
Cancer; 2010 Jun; 116(12):3006-14. PubMed ID: 20564406
[TBL] [Abstract][Full Text] [Related]
12. Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population.
Chan SL; Mo FK; Johnson PJ; Liem GS; Chan TC; Poon MC; Ma BB; Leung TW; Lai PB; Chan AT; Mok TS; Yeo W
J Gastroenterol Hepatol; 2011 Feb; 26(2):340-7. PubMed ID: 21261725
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors of survival in patients with non-resectable hepatocellular carcinoma: hepatitis C versus miscellaneous etiology.
Abbas Z; Siddiqui AU; Luck NH; Hassan M; Mirza R; Naqvi A; Rizvi AH
J Pak Med Assoc; 2008 Nov; 58(11):602-7. PubMed ID: 19024130
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a new prognostic score of death for patients with hepatocellular carcinoma in palliative setting.
Tournoux-Facon C; Paoletti X; Barbare JC; Bouché O; Rougier P; Dahan L; Lombard-Bohas C; Faroux R; Raoul JL; Bedenne L; Bonnetain F
J Hepatol; 2011 Jan; 54(1):108-14. PubMed ID: 21047696
[TBL] [Abstract][Full Text] [Related]
15. Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems.
Cammà C; Di Marco V; Cabibbo G; Latteri F; Sandonato L; Parisi P; Enea M; Attanasio M; Galia M; Alessi N; Licata A; Latteri MA; Craxì A
Aliment Pharmacol Ther; 2008 Jul; 28(1):62-75. PubMed ID: 18373636
[TBL] [Abstract][Full Text] [Related]
16. [Prognosis of hepatocellular carcinoma according to new staging classifications].
Caselitz M; Masche N; Flemming P; Stern C; Manns MP; Wagner S; Kubicka S
Dtsch Med Wochenschr; 2004 Aug; 129(33):1725-30. PubMed ID: 15295682
[TBL] [Abstract][Full Text] [Related]
17. Prospective validation of the Barcelona Clinic Liver Cancer staging system.
Cillo U; Vitale A; Grigoletto F; Farinati F; Brolese A; Zanus G; Neri D; Boccagni P; Srsen N; D'Amico F; Ciarleglio FA; Bridda A; D'Amico DF
J Hepatol; 2006 Apr; 44(4):723-31. PubMed ID: 16488051
[TBL] [Abstract][Full Text] [Related]
18. Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients.
Tateishi R; Yoshida H; Shiina S; Imamura H; Hasegawa K; Teratani T; Obi S; Sato S; Koike Y; Fujishima T; Makuuchi M; Omata M
Gut; 2005 Mar; 54(3):419-25. PubMed ID: 15710994
[TBL] [Abstract][Full Text] [Related]
19. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).
Kudo M; Chung H; Osaki Y
J Gastroenterol; 2003; 38(3):207-15. PubMed ID: 12673442
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implication of serum vascular endothelial growth factor in advanced hepatocellular carcinoma staging.
Yegin EG; Siykhymbayev A; Eren F; Bekiroglu N; Ozdogan OC
Ann Hepatol; 2013; 12(6):915-25. PubMed ID: 24114822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]